Drug eluting stent implantation for the treatment of symptomatic myocardial bridging is associated with favorable peri-procedural results and short-term outcomes

详细信息    查看全文

• 作者：Amit A. Doshi ; Anthony R. Orsini ; Ernest L. Mazzaferri Jr. ; Wade T. Schmidt ; Raymond D. Magorien ; Charles A. Bush
• 关键词：Myocardial bridging ; Myocardial infarction ; Acute coronary syndrome ; Percutaneous coronary intervention ; Drug eluting stent
• 刊名：International Journal of Cardiology
• 出版年：2007
• 出版时间：12 June 2007
• 年：2007
• 卷：118
• 期：3
• 页码：e87-e88
• 全文大小：76 K

文摘

Myocardial bridging is the most common congenital coronary abnormality, and is frequently found on post-mortem cardiac examination. Although often asymptomatic, clinical presentation can vary from unstable angina to sudden cardiac death. Only isolated cases of using drug eluting stents (DES) for bridging segments have been described. Our objective was to retrospectively analyze a series of patients undergoing percutaneous coronary intervention (PCI) with DES for symptomatic myocardial bridging and follow post-procedure outcomes. Results revealed favorable peri-procedural angiographic and short-term clinical results with DES implantation. Although initial data regarding DES implantation for symptomatic myocardial bridging are promising, long-term follow up, particularly related to in-stent restenosis will be important.